Development Pipeline

Development Pipeline

DNX-2401 Tasadenoturev
Recurrent Glioblastoma (+ pembrolizumab) “IGNITE” (planned)
 
Recurrent Glioblastoma (+ pembrolizumab) “CAPTIVE”
 
Pediatric Diffuse Intrinsic Pontine Glioma (DIPG) 1
 
Recurrent Glioblastoma – Intra-arterial Delivery via Mesenchymal Stem Cells 1
 
DNX-2440 OX40L-Armed Virus
Colorectal Cancer and Other Tumors with Liver Metastases
 
Recurrent Glioblastoma 1
 
DNX-2465 Undisclosed
Multiple Solid Tumors; Biomarker Selected Patient Population
 
PlannedOngoing